share_log

HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Raises Price Target to $18

Benzinga ·  Apr 14, 2023 06:22

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Arcadia Biosciences (NASDAQ:RKDA) with a Buy and raises the price target from $3 to $18.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment